Cleared Traditional

K093888 - COOPDECH ENDOBRONCHIAL BLOCKER TUBE (FDA 510(k) Clearance)

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2010
Decision
88d
Days
Class 2
Risk

K093888 is an FDA 510(k) clearance for the COOPDECH ENDOBRONCHIAL BLOCKER TUBE. Classified as Tube, Tracheal/bronchial, Differential Ventilation (w/wo Connector) (product code CBI), Class II - Special Controls.

Submitted by Daiken Medical Co, Ltd. (Tokyo, JP). The FDA issued a Cleared decision on March 16, 2010 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5740 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Daiken Medical Co, Ltd. devices

Submission Details

510(k) Number K093888 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 18, 2009
Decision Date March 16, 2010
Days to Decision 88 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 139d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CBI Tube, Tracheal/bronchial, Differential Ventilation (w/wo Connector)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5740
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CBI Tube, Tracheal/bronchial, Differential Ventilation (w/wo Connector)

All 33
Devices cleared under the same product code (CBI) and FDA review panel - the closest regulatory comparables to K093888.
Endobronchial Blocker Tube (EBT0109)
K251950 · Hangzhou Tappa Medical Technology Co., Ltd. · Mar 2026
Chartis Precision Catheter
K253096 · Pulmonx Corporation · Feb 2026
Disposable Double Lumen Endobronchial Tube
K232529 · Shenzhen Insighters Medical Technology Co., Ltd. · May 2024
Disposable Endobronchial Blocker Tube
K232580 · Shenzhen Insighters Medical Technology Co., Ltd. · Dec 2023
Chartis Precision Catheter
K222340 · Pulmonx Corporation · Dec 2022
Ambu VivaSight 2 DLT, Ambu VivaSight 2 Adapter Cable
K203749 · Ambu A/S · May 2021